Market Overview
The Australia and New Zealand wound care market encompasses advanced wound dressings, traditional wound care products, wound closure devices, and related therapies used across hospitals, community care, and home settings. Australia accounts for the bulk of regional revenue, with its advanced wound care segment alone estimated near USD 330-352 million in 2025, while New Zealand contributes a smaller but steadily growing share. The market is mature in traditional segments such as gauze and basic dressings but still considered under-penetrated in advanced categories relative to Western European comparators.
- •Combined ANZ market valued at approximately USD 635 million in 2025.
- •Forecast compound annual growth rate of 5.3% through the next decade.
- •Advanced wound care products are growing faster than traditional segments.
Growth Drivers
Population aging is the single most powerful structural driver, as Australians over 65 form a rising share of the population and suffer disproportionately from chronic wounds, pressure injuries, and post-surgical complications. The increasing prevalence of diabetes, obesity, and vascular disease is expanding the pool of patients with hard-to-heal wounds, particularly diabetic foot ulcers. Cost containment pressures on public health systems are also encouraging earlier discharge and community-based wound management, which boosts demand for advanced products that can be used safely outside hospitals.
- •Aging population increases incidence of chronic and surgical wounds.
- •Rising diabetes and obesity rates expand the chronic wound patient base.
- •Shift to outpatient and home care drives uptake of advanced dressings.
Segmentation and Regional Analysis
By product, the market splits between advanced wound care (hydrocolloids, hydrogels, foams, films, alginates, collagen, antimicrobial dressings, and negative pressure wound therapy) and traditional wound care (gauze, bandages, tapes, and basic dressings), with advanced products gaining share each year. By application, chronic wounds represent the largest and fastest-growing category, followed by acute wounds and surgical wounds. By end use, hospitals remain dominant, but long-term care facilities, ambulatory clinics, and home healthcare are expanding more quickly, particularly in major Australian metropolitan areas and across New Zealand's district health boards.
- •Advanced wound care is the fastest-growing product category.
- •Chronic wounds are the leading application segment by revenue.
- •Hospital procurement leads, with home care as the fastest-rising channel.
Trends and Outlook
What are the recent trends and outlook?
The most visible trend is the steady migration from traditional gauze-based care toward advanced dressings and active therapies, including negative pressure wound therapy and antimicrobial products that address bioburden in chronic wounds. Digital and connected wound assessment tools are beginning to appear in pilot programs, supporting telehealth follow-up for patients managed at home. Sustainability is also emerging as a procurement criterion, with hospitals asking suppliers about packaging waste and recyclable materials. The outlook through the end of the decade remains constructive, with double-digit growth expected in advanced categories even as the overall market expands at a mid-single-digit pace.
- •Advanced and active wound therapies are taking share from traditional products.
- •Digital wound assessment and telehealth-enabled follow-up are gaining traction.
- •Sustainability considerations are increasingly influencing hospital purchasing.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.